Electroretinography is a diagnostic medical test that is used to evaluate the health and function of the retina. It provides objective measurements of the retina's electrical activity by recording how it responds to light stimulus. The test involves placing electrodes on the surface of the eye and the scalp of the patient. A light source is then used to illuminate the retina while recording any electrical responses. The electroretinogram or electroretinogram (ERG) measures the mass electric response of the retina and can help detect retinal abnormalities that are associated with diseases like retinitis pigmentosa. Rising prevalence of retinal disorders worldwide is anticipated to drive increased reliance on ERG for improved diagnosis and management of ocular conditions.
Market Dynamics:
Global electroretinogram market is driven by the growing geriatric population prone to age-related retinal diseases, rising incidence of diabetic retinopathy, growing awareness about eye care, and technological advancements incorporating and multifocal electroretinography. However, the market growth can be restrained by the high cost of electroretinogram devices and non-availability of skilled professionals in many developing regions. Emerging economies offer lucrative opportunities for market players as they witness rapid economic development and healthcare infrastructure expansion. Manufacturers investing in research and development (R&D) of portable devices for point-of-care (POC) testing can also open up opportunities.
A primary driver is the increasing geriatric population, which is more susceptible to age-related retinal diseases such as macular degeneration and glaucoma. As the number of elderly individuals rises globally, the demand for ERG for the diagnosis and monitoring of these conditions also increases. Another significant factor is the rising incidence of diabetic retinopathy, a complication of diabetes that affects the eyes. Growing prevalence of diabetes worldwide has led to an increase in demand for early detection and treatment of eye-related complications, thereby propelling the use of ERG devices. Heightened awareness about eye care and the importance of regular eye examinations has further stimulated the market. Public health initiatives and educational campaigns about eye health have encouraged more people to seek comprehensive eye examinations, which often include ERG testing. Technological advancements, such as the incorporation of multifocal electroretinography, have improved the accuracy and efficiency of ERG devices. These innovations have expanded the applications of ERG in diagnosing and treating a variety of retinal conditions, thus making it a valuable tool for ophthalmologists.
For instance, in October 2022, according to data provided by the World Health Organization (WHO), in 2020, the number of people aged 60 years and older outnumbered children younger than 5 years. Between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. The share of the population aged 60 years and over will increase from 1 million in 2020 to 1.4 million. By 2050, the world’s population of people aged 60 years and olders will double (2.1 million). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million.
Key features of the study:
Detailed Segmentation:
Detailed Segmentation:
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients